Leading Biopharma Experts Gather at Veeva R&D Summit to Innovate Medicinal Development

Innovating Medicine: The Veeva R&D and Quality Summit



The biopharma industry is on the brink of a radical transformation, as evidenced by the upcoming Veeva R&D and Quality Summit taking place in Madrid, Spain, on June 4-5. This gathering is expected to be one of the largest in Europe, bringing together more than 1,400 professionals within the life sciences sector. As key stakeholders in the industry, they are poised to share insights and discuss advancements that could reshape the future of drug development and manufacturing.

Keynote Speakers: A Wealth of Expertise



Veeva Systems, the global leader in cloud software for the life sciences sector, has announced an impressive lineup of keynote speakers at this event. Notable figures from influential companies such as Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva will take the stage to discuss how connected platforms and artificial intelligence can streamline the development of new medicines. Their varied perspectives promise to offer unique insights into the complexities of modern biopharma.

The opening keynote will showcase Veeva AI, an initiative aimed at integrating artificial intelligence into the Veeva Vault Platform and Veeva applications. This cutting-edge technology is designed to automate critical functions, enhance productivity, and ultimately improve the efficiency of drug development processes.

Sessions Covering Vital Topics



The summit offers more than 100 sessions tailored to address the key concerns of clinical, regulatory, safety, and quality sectors. Each session is crafted to foster collaboration and knowledge sharing among professionals. For instance, Bayer will present on its innovative approach to streamlining clinical infrastructures with a customer-centric mindset. Meanwhile, Lonza will discuss how the changing dynamics of the industry are reshaping quality management across partnerships.

MSD will share its progress in advancing pharmacovigilance operations through a trusted data foundation, while Novo Nordisk will highlight its use of the Veeva Development Cloud to enhance trial efficiency by unifying business and IT teams. Furthermore, Teva's presentation will focus on its strategies to adapt to regulatory changes through innovation and data-driven methodologies.

The Importance of Collaboration



As Rik Van Mol, senior vice president of R&D and Quality at Veeva, aptly noted, “Fresh thinking and a strong community are essential to transforming how we bring medicines to patients.” The summit is strategically designed to ignite new ideas and encourage leaders to collaborate in shaping the future landscape of the biopharmaceutical industry.

With a shared commitment to innovation and excellence, Veeva seeks to inspire attendees to tackle challenges and seize opportunities within their organizations. The sessions are geared toward fostering a collaborative environment while exploring breakthroughs that may lead to improved patient outcomes.

An Exclusive Gathering



It is important to note that the Veeva R&D and Quality Summit is an exclusive event, open solely to life sciences professionals. This exclusivity ensures that discussions remain focused and relevant to the field, further enhancing the value of connections made during the event. Participants are encouraged to engage actively, as networking is a crucial component of knowledge exchange at such prominent gatherings.

Future-focused strategies and discussions poised to take place at the summit could significantly influence the direction of the biopharma industry. To register and review the agenda, interested individuals can visit Veeva's official website.

About Veeva Systems



Founded with a commitment to innovation and customer success, Veeva Systems serves over 1,000 customers globally, ranging from the largest biopharmaceutical companies to emerging biotech firms. The company operates under the principles of a Public Benefit Corporation, prioritizing the needs and interests of all stakeholders involved—customers, employees, shareholders, and the industries it serves. To learn more about Veeva's offerings, visit veeva.com/eu.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.